# Pomegranate-vascular-function-meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/pomegranate-vascular-function-meta-analysis-evidence-review
Category: evidence-review
Summary: Pomegranate-vascular-function-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-08-07
Reviewed by: Migaku Evidence Review
# Pomegranate-vascular-function-meta-analysis: What the Evidence Says

## Quick Answer

Pomegranate-vascular-function-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Acute Effects of a High-Fat Meal Enriched with Pomegranate Seed Oil on Postprandial Lipemia and Endothelial Function in Postmenopausal Women: a Randomized Controlled Crossover Trial | randomized trial | 2 | 2026-03-01 | 10.1016/j.tjnut.2026.101374 |
| Phytochemical Diversity of Punica granatum L. and Its Multi-Target Biological Functions | narrative review | 3 | 2026-04-21 | 10.3390/nu18081306 |

## What The Sources Report

- Hormonal changes associated with this stage of life contribute to a higher CVD risk, driven by factors such as visceral obesity, atherogenic dyslipidemia, vascular dysfunction, and high blood pressure (BP). [Almoraie Manal M (2026); evidence level 2]
- However, a direct association between menopause and increased risk of CVD events has only been confirmed in cases of early (premature) menopause. [Almoraie Manal M (2026); evidence level 2]
- Archaeobotanical evidence indicates that the pomegranate was domesticated at a very early stage, dating back to the Neolithic period. [Kobylińska Zofia (2026); evidence level 3]
- To address these gaps, this review consolidates evidence into a translational chain that links product/matrix characteristics to phytochemical profiles, bioaccessibility and metabolism, and downstream multi-target biological outcomes. [Kobylińska Zofia (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For pomegranate-vascular-function-meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Almoraie Manal M (2026). Acute Effects of a High-Fat Meal Enriched with Pomegranate Seed Oil on Postprandial Lipemia and Endothelial Function in Postmenopausal Women: a Randomized Controlled Crossover Trial. DOI: 10.1016/j.tjnut.2026.101374. PMCID: PMC13014500. PMID: 41580088. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13014500/
- Kobylińska Zofia (2026). Phytochemical Diversity of Punica granatum L. and Its Multi-Target Biological Functions. DOI: 10.3390/nu18081306. PMCID: PMC13118560. PMID: 42075117. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13118560/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.